Recital 22, Regulation (EU) 2025/2086

In forcesince 17 Oct 2025

In order to ensure good administration and timely availability of joint clinical assessment reports of medical devices, deadlines should be set for the Commission’s assessment on whether the dossier submitted by the health technology developer for joint clinical assessment of the medical device meets the requirements laid down in Article 9(2), (3) and (4), of Regulation (EU) 2021/2282. In order to ensure the smooth conduct of joint clinical assessment, the Commission should consult, as appropriate, the assessor and co-assessor when carrying out the assessment.